4//SEC Filing
Holtzman Douglas 4
Accession 0001209191-22-061736
CIK 0001786255other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 6:36 PM ET
Size
6.1 KB
Accession
0001209191-22-061736
Insider Transaction Report
Form 4
Icosavax, Inc.ICVX
Holtzman Douglas
Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-12-15$11.14/sh−19,648$218,963→ 2,792 total(indirect: By Stanley Holtzman)
Holdings
- 293,258
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.08 to $11.26. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Douglas Holtzman, Ph.D. holds power-of-attorney (POA) over the shares owned by Stanley Holtzman. As POA, Dr. Holtzman holds voting and dispositive control over such shares. Dr. Holtzman disclaims beneficial ownership of the shares over which he has POA except to the extent of any pecuniary interest therein.
Documents
Issuer
Icosavax, Inc.
CIK 0001786255
Entity typeother
Related Parties
1- filerCIK 0001874371
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 6:36 PM ET
- Size
- 6.1 KB